On 21 October, the ACTION Project joined with Médecins Sans Frontières (MSF), the International Union Against Tuberculosis and Lung Disease and Global Health Advocates in hosting a symposium at the European Development Days in Sweden.
According to a report – Cough up for TB! – released at the symposium by MSF, the largest European countries are lagging far behind the US in funding of tuberculosis (TB) research and development. The report shows that all European countries in the analysis, except for Sweden, have failed to prioritise TB and are contributing to huge global underfunding at a time when 1.7 million people die every year from the disease.
According to the report the UK is paying only 50 per cent of its fair share, while Germany and Italy are doing much worse at 23 and 11 per cent. With an average contribution of just over a third of their fair share, the European contribution is dwarfed by the US which is contributing two thirds of its fair share. Of the estimated 1.45 billion Euro required to fully scale-up TB research, only 350 million Euro (or 24 percent) is currently invested worldwide.
Hear from Dr. Christophe Fournier (President of MSF), Dr. Pehrolov Pehrson (MSF Sweden), Dr. Frauke Jochims (MSF Geneva) and Dr. Nils Billo (International Union Against Tuberculosis and Lung Disease) in the following video on the importance of increased funding for TB research and development.